Drug Approval | March 21, 2022
Alembic Pharmaceuticals receives USFDA approval for Lacosamide tablets
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
The investment will accelerate the overall Sarclisa development program
The brand has added a range of exciting new products especially formulated for oily skin.
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
TATA MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
It is the world’s first DNA-based Covid vaccine
The platform will provide a safe and nurturing space for women, and non-binary individuals
A high-value proposition recyclable film packed with industry-leading barrier and metal bond performance, sustainability quotient and U.S. FDA compliant
Godrej and Boyce and Isgec Engineering have confirmed receiving the orders
Subscribe To Our Newsletter & Stay Updated
